Nesolicaftor (PTI-428)

Nesolicaftor is a new type of modulator called an amplifier. Amplifiers increase the amount of CFTR protein in the cell. This makes more CFTR protein available for other therapies, such correctors and potentiators, to work on.

Status

Phase 2 studies have been conducted to test the safety and effectiveness of nesolicaftor alone and in combination with two other CFTR modulators, posenacaftor (PTI-801) and dirocaftor (PTI-808).

Sponsor

This program is sponsored by Proteostasis Therapeutics. It is being conducted through the Therapeutics Development Network.